- Patent Title: GATA3 inhibitors for the promotion of subcutaneous fat deposition
-
Application No.: US16909755Application Date: 2020-06-23
-
Publication No.: US11976282B2Publication Date: 2024-05-07
- Inventor: Mohamed Elrayess , Layla Almansoori
- Applicant: QATAR UNIVERSITY
- Applicant Address: QA Doha
- Assignee: QATAR UNIVERSITY
- Current Assignee: QATAR UNIVERSITY
- Current Assignee Address: QA Doha
- Agency: Squire Patton Boggs (US) LLP
- Main IPC: C12N15/00
- IPC: C12N15/00 ; A61K9/00 ; A61P3/10 ; C12N15/113
Abstract:
Methods and compositions using dnayzme-based GATA3 inhibitors for the treatment of insulin resistance and Type II diabetes, for the stimulation of adipogenesis in vivo, and for the promotion of fat redistribution are disclosed.
Public/Granted literature
Information query
IPC分类:
